|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
EBSCO_ocn794223042 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
120524s2011 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d E7B
|d YDXCP
|d OCLCF
|d OCLCQ
|d AGLDB
|d CNNOR
|d MOR
|d CNKEY
|d AZK
|d PIFAG
|d OCLCQ
|d U3W
|d STF
|d WRM
|d VTS
|d NRAMU
|d VT2
|d TOF
|d AU@
|d OCLCQ
|d A6Q
|d M8D
|d OCLCO
|d OCLCQ
|d QGK
|d S2H
|d OCLCO
|
| 019 |
|
|
|a 851158030
|a 961573211
|a 962684194
|a 988530737
|a 992100288
|a 1037920357
|a 1038665178
|a 1045509809
|a 1055379556
|a 1081275428
|a 1083615601
|a 1152999003
|a 1228585488
|a 1259097096
|a 1289522970
|
| 020 |
|
|
|a 9781617613784
|q (electronic bk.)
|
| 020 |
|
|
|a 1617613789
|q (electronic bk.)
|
| 020 |
|
|
|a 1617611115
|
| 020 |
|
|
|a 9781617611117
|
| 020 |
|
|
|z 9781617611117
|
| 029 |
1 |
|
|a AU@
|b 000051829489
|
| 029 |
1 |
|
|a AU@
|b 000053002014
|
| 029 |
1 |
|
|a DEBBG
|b BV043152147
|
| 029 |
1 |
|
|a DEBSZ
|b 42142043X
|
| 029 |
1 |
|
|a GBVCP
|b 804000654
|
| 029 |
1 |
|
|a NZ1
|b 15025350
|
| 035 |
|
|
|a (OCoLC)794223042
|z (OCoLC)851158030
|z (OCoLC)961573211
|z (OCoLC)962684194
|z (OCoLC)988530737
|z (OCoLC)992100288
|z (OCoLC)1037920357
|z (OCoLC)1038665178
|z (OCoLC)1045509809
|z (OCoLC)1055379556
|z (OCoLC)1081275428
|z (OCoLC)1083615601
|z (OCoLC)1152999003
|z (OCoLC)1228585488
|z (OCoLC)1259097096
|z (OCoLC)1289522970
|
| 050 |
|
4 |
|a RC267
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Horizons in cancer research.
|n Volume 42 /
|c Hiroto S. Watanabe, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science,
|c Ã2011.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Horizons in cancer research ;
|v 42
|
| 500 |
|
|
|a "Nova biomedical."
|
| 500 |
|
|
|a Title from PDF title page (viewed on May 23, 2012).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a HORIZONS IN CANCER RESEARCH. VOLUME 42; HORIZONS IN CANCER RESEARCH. VOLUME 42 ; Contents ; Preface ; Signaling Pathways as Biomarkers in Human Renal Cell Carcinoma ; Summary ; Introduction ; Carbonic Anhydrase 9 ; GLUT Transporters ; Conclusion ; Acknowledgments ; References ; Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis and Prostate Tumor Growth ; Abstract ; Conclusion ; Acknowledgments ; References ; Elapsed Times in the Management of Early Stage Breast Cancer ; Abstract ; Introduction ; Detection to Treatment ; Detection to Diagnosis.
|
| 505 |
8 |
|
|a Detection to Surgery Surgery to Chemotherapy ; Surgery to Radiotherapy ; Summary & Caveats ; What are the predictors of longer elapsed times in Canada? ; Detection to Diagnosis ; Detection to Surgery ; Surgery to Chemotherapy ; Surgery to Radiotherapy ; Summary & Caveats ; A multi-interval multi-resolution analytics framework ; Conclusions ; Acknowledgments ; References ; Positional Cloning of Tumor Suppressor Genes from 3p21.3 Involved in Major Human Cancers ; 1. Abstract ; 2. Introduction ; 3. Results.
|
| 505 |
8 |
|
|a A) Localization of Critical Regions on the Short Arm of Chromosome 3 Using Allelotyping of the Dense Set of Polymorphic Markers Multiple interstitial deletions were found in prevalence to terminal deletions in 3p in five epithelial tumor types ; Chromosome 3p "hot spots" affected in major epithelial tumors ; Contribution of amplification events in allelic alterations of 3p microsatellites ; Correlation of 3p allelic alterations with tumor progression ; b) Careful Mapping of LUCA and AP20 Regions Using Real Time Quantitative PCR ; QPCR for detection copy number changes.
|
| 505 |
8 |
|
|a QPCR results for RCC, BC and SCLC tumor samples and cell lines Comparison of LOH and QPCR data. fine deletion mapping of homozygous deletions ; Complex 3p rearrangements in major epithelial cancers ; c) NotI-Microarrays to Identify Cancer Causing Genes and Develop Biomarkers for Early Diagnosis, Prognosis and Prediction of Major Types of Cancer ; d) Identification of Novel Tumor Suppressor Genes ; Conclusion ; Acknowledgments ; References ; Novel Methylation-Dependent Markers/Tumor Suppressor Genes Involved in the Development of Renal Cell Cancer ; Abstract ; Introduction.
|
| 505 |
8 |
|
|a RCC Methylation Profiles of RASSF1A, SEMA3B, RARbeta2, RHOA, GPX1, USP4 Genes Genes in the LUCA Critical Region (3p21.31) ; Genes from the Distal 3p Region (3p26-P22) ; RCC Specific Methylation Profile for Six 3p Genes ; Methylation Pattern of RASSF1A, RAR-Beta2, SEMA3B, GPX1 and Tumor Progression ; Expression Profiles of Cancer Associated Genes: RBSP3, SEMA3B, SEMA3F, NPRL2, HYAL1, HYAL2, ITGA9, VILL, CHL1, and ACY1 in RCC ; High Mutation Frequency of the Tumor Suppressors RASSF1 and RBSP3 (CTDSPL) in RCC ; NotI Microarrays for Identification of RCC Biomarkers ; Conclusion.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cancer
|x Research.
|
| 650 |
|
6 |
|a Cancer
|x Recherche.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Research
|2 fast
|
| 700 |
1 |
|
|a Watanabe, Hiroto S.
|
| 776 |
|
|
|z 1-61761-111-5
|
| 830 |
|
0 |
|a Horizons in cancer research ;
|v 42.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=450544
|z Texto completo
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10663019
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 450544
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7666847
|
| 994 |
|
|
|a 92
|b IZTAP
|
